Market Cap 50.62B
Revenue (ttm) 7.47B
Net Income (ttm) 722.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 36.61
Profit Margin 9.67%
Debt to Equity Ratio 0.50
Volume 9,403
Avg Vol 112,872
Day's Range N/A - N/A
Shares Out 722.26M
Stochastic %K 81%
Beta 1.17
Analysts Strong Sell
Price Target $75.50

Company Profile

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs through...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 41 61 316 81 11
Address:
Muenchensteinerstrasse 38, Basel, Switzerland
Latest News on LZAGY
No data available.